Global leader announces investment at Markham Vale
Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield.
The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM.
Scheduled for completion in the 2018, the facility will include the installation of state-of-the-art technology
The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing facility based in Somercotes.
“Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Sterigenics. “We continue to invest in our global network to meet our customers’ growing demand for gamma irradiation capacity as a critical step in their product development processes. Our new Markham Vale facility will strengthen our ability to serve our European customers, particularly in the MedTech and pharmaceutical fields, and help them innovate with success.”
“Our Markham Vale North facility is strategically located to serve the needs of our European customers,” said Adrian Wye, Director of UK Operations. “Its prime location at the heart of the UK’s motorway network will provide an optimum location for their supply chain logistics. And our facility’s high-tech capabilities will deliver the turnaround times necessary to distribute their products to market quickly.”
Find out more about investing in Chesterfield
